A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation

Metabolomics

Volumn 9, Issue 6, 2013, Pages 1262-1273

  Kozlowska, Justyna ^a   Rivett, Damian W ^a   Vermeer, Louic S ^a   Carroll, Mary P ^b   Bruce, Kenneth D ^a   James Mason, A ^a   Rogers, Geraint B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Lung function; NMR; Pseudomonal

Indexed keywords

RNA 16S;

ADULT; ARTICLE; AUXOTROPHY; BACTERIAL GROWTH; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FUNCTION; MALE; METABOLITE; NONHUMAN; PH; PHENOTYPE; PIGMENTATION; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SPECIES DIVERSITY; SPUTUM ANALYSIS;

PSEUDOMONAS AERUGINOSA;

EID: 84887989964     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0538-5     Document Type: Article

References (53)

1. Aaron, S. D., Kottachchi, D., Ferris, W. J., Vandemheen, K. L., St Denis, M. L., Plouffe, A., et al. (2004). Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis. European Respiratory Journal, 24, 631-637.
2. Andersson, M. (2009). A comparison of nine PLS1 algorithms. Journal of Chemometrics, 23, 518-529.
3. Armougom, F., Bittar, F., Stremler, N., Rolain, J. M., Robert, C., Dubus, J. C., et al. (2009). Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. European Journal of Clinical Microbiology and Infectious Diseases, 28, 1151-1154.
4. Barth, A. L., & Pitt, T. L. (1995). Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. Journal of Clinical Microbiology, 33, 2192-2194.
5. 1H NMR spectral peaks if metabolites in huge sets of urines. Analytica Chimica Acta, 685, 186-195.
6. Bernier, S. P., Ha, D. G., Khan, W., Merritt, J. H., & O'Toole, G. A. (2011). Modulation of Pseudomonas aeruginosa surface-associated group behaviors by individual amino acids through c-di-GMP signaling. Research in Microbiology, 162, 680-688.
7. Bjarnsholt, T., Jensen, P. Ø., Jakobsen, T. H., Phipps, R., Nielsen, A. K., Rybtke, M. T., et al. (2010). Scandinavian cystic fibrosis study consortium. Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS ONE, 5, e10115.
8. Boucher, R. C. (2004). New concepts of the pathogenesis of cystic fibrosis lung disease. European Respiratory Journal, 23, 146-158.
9. CF Foundation. 2007. Patient registry annual data report. http://cff. org/UploadedFiles/research/ClinicalResearch/2007-Patient-Registry-Report. pdf.
10. Ciofu, O., Mandsberg, L. F., Wang, H., & Høiby, N. (2012). Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections. FEMS Immunology and Medical Microbiology, 65, 215-225.
11. Clary-Meinesz, C., Mouroux, J., Cosson, J., Huitorel, P., & Blaive, B. (1998). Influence of external pH on ciliary beat frequency in human bronchi and bronchioles. European Respiratory Journal, 11, 330-333.
12. 1H NMR spectroscopic metabonomic studies. Analytical Chemistry, 77, 517-526.
13. Dean, M., & Santis, G. (1994). Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Human Genetics, 93, 364-368.
14. 1H NMR metabonomics. Analytical Chemistry, 78, 4281-4290.
15. Dunaj, S. J., Vallino, J. J., Hines, M. E., Gay, M., Kobyljanec, C., & Rooney-Varga, J. N. (2012). Relationships between soil organic matter, nutrients, bacterial community structure, and the performance of microbial fuel cells. Environmental Science and Technology, 46, 1914-1922.
16. Duncan, S. H., Louis, P., Thomson, J. M., & Flint, H. J. (2009). The role of pH in determining the species composition of the human colonic microbiota. Environmental Microbiology, 11, 2112-2122.
17. Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., & Gibson, R. L. (2002). Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatric Pulmonology, 34, 91-100.
18. Feizabadi, M. M., Majnooni, A., Nomanpour, B., Fatolahzadeh, B., Raji, N., Delfani, S., et al. (2010). Direct detection of Pseudomonas aeruginosa from patients with healthcare associated pneumonia by real time PCR. Infection, Genetics and Evolution, 10, 1247-1251.
19. Frimmersdorf, E., Horatzek, S., Pelnikevich, A., Wiehlmann, L., & Schomburg, D. (2010). How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach. Environmental Microbiology, 12, 1734-1747.
20. Fung, C., Naughton, S., Turnbull, L., Tingpej, P., Rose, B., Arthur, J., et al. (2010). Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. Journal of Medical Microbiology, 59, 1089-1100.
21. Gjersing, E. L., Herberg, J. L., Horn, J., Schaldach, C. M., & Maxwell, R. S. (2007). NMR metabolomics of planktonic and biofilm modes of growth in Pseudomonas aeruginosa. Analytical Chemistry, 79, 8037-8045.
22. Hwang, T.-L., & Shaka, A. J. (1995). Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. Journal of Magnetic Resonance, 112, 275-279.
23. Inglis, S. K., Corboz, M. R., & Ballard, S. T. (1998). Effect of anion secretion inhibitors on mucin content of airway submucosal gland ducts. American Journal of Physics, 274, L762-L766.
24. Kloosterman, T. G., & Kuipers, O. P. (2011). Regulation of arginine acquisition and virulence gene expression in the human pathogen Streptococcus pneumoniae by transcription regulators ArgR1 and AhrC. Journal of Biological Chemistry, 286, 44594-44605.
25. Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., et al. (2010). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax, 65, 57-62.
26. Kosorok, M. R., Zeng, L., West, S. E., Rock, M. J., Splaingard, M. L., Laxova, A., et al. (2001). Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatric Pulmonology, 32, 277-287.
27. Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002). Lung infections associated with cystic fibrosis. Clinical Microbiology Reviews, 15, 194-222.
28. Mitsui, Y., Matsumura, K., Kondo, C., & Takashima, R. (1976). The role of mucin on experimental Pseudomonas keratitis in rabbits. Investigative Ophthalmology, 15, 208-210.
29. Nakada, Y., & Itoh, Y. (2003). Identification of the putrescine biosynthetic genes in Pseudomonas aeruginosa and characterization of agmatine deiminase and N-carbamoylputrescine amidohydrolase of the arginine decarboxylase pathway. Microbiology, 149, 707-714.
30. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., et al. (2011). Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science, 334, 982.
31. Palmer, K. L., Aye, L. M., & Whiteley, M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. Journal of Bacteriology, 189, 8079-8087.
32. Palmer, K. L., Mashburn, L. M., Singh, P. K., & Whiteley, M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. Journal of Bacteriology, 187, 5267-5277.
33. Renders, N., Römling, Y., Verbrugh, H., & van Belkum, A. (1996). Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. Journal of Clinical Microbiology, 34, 3190-3195.
34. Resat, H., Bailey, V., McCue, L. A., & Konopka, A. (2012). Modeling microbial dynamics in heterogeneous environments: growth on soil carbon sources. Microbial Ecology, 63, 883-897.
35. Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., & Bruce, K. D. (2004). Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. Journal of Clinical Microbiology, 42, 5176-5183.
36. Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., Kehagia, V., et al. (2006). Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. Journal of Clinical Microbiology, 44, 2601-2604.
37. Rogosa, M., & Bishop, F. S. (1964). The genus Veillonella II. Nutritional studies. Journal of Bacteriology, 87, 574-580.
38. Romanowski, K., Zaborin, A., Fernandez, H., Poroyko, V., Valuckaite, V., Gerdes, S., et al. (2011). Prevention of siderophore- mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH. BMC Microbiology, 11, 212.
39. Rosenfeld, M., Emerson, J., Williams-Warren, J., Pepe, M., Smith, A., Montgomery, A. B., et al. (2001). Defining a pulmonary exacerbation in cystic fibrosis. Journal of Pediatrics, 139, 359-365.
40. Shrout, J. D., Chopp, D. L., Just, C. L., Hentzer, M., Givskov, M., & Parsek, M. R. (2006). The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Molecular Microbiology, 62, 1264-1277.
41. Son, M. S., Matthews, W. J, Jr, Kang, Y., Nguyen, D. T., & Hoang, T. T. (2007). In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infection and Immunity, 75, 5313-5324.
42. Sriramulu, D. D., Lünsdorf, H., Lam, J. S., & Römling, U. (2004). Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. Journal of Medical Microbiology, 54, 667-676.
43. Stressmann, F. A., Rogers, G. B., Marsh, P., Lilley, A. K., Daniels, T. W., Carroll, M. P., et al. (2011). Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? Journal of Cystic Fibrosis, 10, 357-365.
44. Stressmann, F. A., Rogers, G. B., van der Gast, C. J., Marsh, P., Vermeer, L. S., Carroll, M. P., et al. (2012). Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax, 67, 867-873.
45. Tomasi, G., van den Berg, F., & Andersson, C. (2004). Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data. Journal of Chemometrics, 18, 231-241.
46. Tunney, M. M., Klem, E. R., Fodor, A. A., Gilpin, D. F., Moriarty, T. F., McGrath, S. J., et al. (2011). Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax, 66, 579-584.
47. Ulrich, E. L., Akutsu, H., Doreleijers, J. F., Harano, Y., Ioannidis, Y. E., Lin, J., et al. (2007). BioMagResBank. Nucleic Acids Research, 36, D402-D408.
48. van der Gast, C. J., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W., et al. (2011). Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME Journal, 5, 780-791.
49. Vermeer, L. S., Fruhwirth, G. O., Pandya, P., Ng, T., & Mason, A. J. (2012). NMR metabolomics of MTLn3E breast cancer cells identifies a role for CxCR4 in lipid and choline regulation. Journal of Proteome Research, 11, 2996-3003.
50. Walker, A. W., & Duncan, S. H. (2005). McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Applied and Environmental Microbiology, 71, 3692-3700.
51. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic Acids Research, 37, D603-D610.
52. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., et al. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. The Journal of Clinical Investigation, 109, 317-325.
53. Yoon, S. S., Hennigan, R. F., Hilliard, G. M., Ochsner, U. A., Parvatiyar, K., Kamani, M. C., et al. (2002). Pseudomonas aeruginosa anaerobic respiration in biofilms. Relationships to cystic fibrosis pathogenesis. Developmental Cell, 3, 593-603.